Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 49,700 KRW
Change Today +500.00 / 1.02%
Volume 23.4K
As of 9:16 PM 08/30/15 All times are local (Market data is delayed by at least 15 minutes).

dongkook pharmaceutical co l (086450) Snapshot

Open
49,350
Previous Close
49,200
Day High
50,400
Day Low
49,350
52 Week High
07/24/15 - 73,500
52 Week Low
09/2/14 - 29,400
Market Cap
441.9B
Average Volume 10 Days
68.0K
EPS TTM
2,430
Shares Outstanding
8.9M
EX-Date
12/29/14
P/E TM
20.5x
Dividend
300.00
Dividend Yield
0.60%
Current Stock Chart for DONGKOOK PHARMACEUTICAL CO L (086450)

Related News

No related news articles were found.

dongkook pharmaceutical co l (086450) Related Businessweek News

No Related Businessweek News Found

dongkook pharmaceutical co l (086450) Details

Dong Kook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. The company offers Alprostadil, Teicoplanin, Propofol, Triptorelin, Iopamidol, Octreotide LAR, Gadopentetate dimeglumine, Leuprorelin Acetate, Sodium Hyaluronate, and Streptokinase injection products; and health care products comprising Gamma Linolenic acid, Spirulina, calcium tablets, Propolis liquids and capsules, and Vital Joint Glucosamine products, as well as dietary supplements, multi-vitamins, and Omega-3 products. It also provides Bellast L24 and soft injection products, endoscopic trocar, and medical components, as well as stitches and staplers used for suturing in laparoscopic surgery or laparotomy, and devices for endoscope. The company was formerly known as UEC & Co., Ltd. and changed its name to Dong Kook Pharmaceutical Co., Ltd. in March 1982. Dong Kook Pharmaceutical Co., Ltd. was founded in 1968 and is based in Seoul, South Korea.

Founded in 1968

dongkook pharmaceutical co l (086450) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dongkook pharmaceutical co l (086450) Key Developments

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: Auditorium Building B1. Agenda: To consider approval of financial statements for the year ended December 31, 2014; to consider appointment of directors; and to consider approval of the remuneration.

Probi Announces Distribution Agreement with Dongkook Pharmaceutical

Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd. for the distribution of Probi's gut health product, Probi Mage®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014. Dongkook will launch Probi Mage® as a dietary supplement in department stores and TV/Internet home shopping.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
086450:KS 49,700.00 KRW +500.00

086450 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 086450.
View Industry Companies
 

Industry Analysis

086450

Industry Average

Valuation 086450 Industry Range
Price/Earnings 19.6x
Price/Sales 1.8x
Price/Book 2.3x
Price/Cash Flow 19.2x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DONGKOOK PHARMACEUTICAL CO L, please visit www.dkpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.